ArticleFrontiers in cell and developmental biology2026
The impact of the interaction between ovarian markers and the endometrium on the outcomes of assisted reproduction.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the interaction effects of anti-Müllerian hormone (AMH), antral follicle count (AFC), basal follicle-stimulating hormone (FSH), and endometrial thickness on the outcomes of assisted reproductive technology (ART). Methods: This retrospective cohort study included 12,071 infertile patients with endometrial thickness of 7-14 mm who underwent fresh embryo transfer at a large reproductive medical center in Chengdu, China, between 2019 and 2022. Optimal thresholds for AMH, AFC, and basal FSH were determined using receiver operating characteristic (ROC) curve analysis, and patients were subsequently stratified into relatively normal and abnormal ovarian response groups based on these cut-offs. Cox proportional hazards models were employed to assess the association between endometrial thickness and pregnancy outcomes, including biochemical pregnancy, clinical pregnancy, and live birth. Stratified analyses and interaction tests were further conducted to evaluate the modifying effects of AMH, AFC, and basal FSH levels on this association. Sensitivity analyses were performed to verify the robustness of the findings. Results: Multivariable-adjusted Cox regression indicated that among patients with AMH ≥2.59 ng/mL or AFC ≥11, each 1-mm increase in endometrial thickness was associated with modest outcome improvements: a 1.5% increase in biochemical pregnancy rate [hazard ratio (HR) 95% confidence interval (CI): 1.015 (1.002, 1.029)], a 0.8% increase in clinical pregnancy rate [HR 95% CI: 1.008 (1.001, 1.015)], and a 0.7% increase in live birth rate [HR 95% CI: 1.007 (1.001, 1.013)]. Baseline FSH levels showed no significant association with pregnancy outcomes. Statistically significant interactions were observed between endometrial thickness and both AMH and AFC ( Conclusion: Among patients with normal ovarian reserve, endometrial thickness within the range of 7-14 mm showed a positive albeit modest association with ART pregnancy outcomes, with AMH and AFC levels exerting a modifying effect on this association.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.